Skip to main content
usedby
CelonisusedbyNovo Nordisk

How Novo Nordisk uses Celonis

ConfirmedVendor case study · Checked Oct 8, 2026
View captured proof

The use case: how Novo Nordisk deploys Celonis

Novo Nordisk built a digital twin of its clinical trials application process in Celonis and uses Celonis Process Intelligence to power a fleet of AI agents that automate regulated clinical development workflows. It also uses the platform to diagnose whether problems lie in people, process or technology and to validate KPIs during IT modernization.

In the customer’s words

Without Process Intelligence, Enterprise AI at scale is hopeful thinking.
Stephanie Bova, Corporate Vice President and Digital Transformation Officer, Research and Development, Novo Nordisk — Source

Other AI tools used by Novo Nordisk

Other public relationships recorded on usedby.

ClaudeConfirmedAppZenObservedCausalyObservedCradleObservedDataikuObservedNeonObserved
Explore Novo Nordisk’s AI stack

Celonis users in Biotech & Pharma

Companies in the same sector, with public evidence.

AstraZenecaConfirmedIQVIAConfirmedSTADAConfirmedVetterConfirmed
See all Celonis customers

More stories

Go straight to the source

Based on Celonis’s published case study. We check the public evidence; the results are reported by the vendor.

celonis.com
Last checked
Oct 8, 2026
celonis.comCaptured Celonis case study about Novo NordiskOpen source capture
What the story claims, and what we checked

What we compared with the page.

  • The figure: 100+Checked

    The figure is on the page; its label is our wording.

  • The passage quoted aboveChecked

    Copied word for word from the page, near the name of Novo Nordisk.

  • Novo Nordisk uses CelonisChecked

    Confirmed line.

  • The result itselfNot checked

    We quote it; we did not measure it.

Today, Novo Nordisk are transforming into an agentic enterprise. They’re powering a fleet of over 100 AI agents with Celonis to revolutionize clinical development. The ambition: shaving 12 months or more off drug development time to get medications into the hands of patients faster.
From the page. celonis.com